Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease

N Esser, N Paquot, AJ Scheen - Expert opinion on investigational …, 2015 - Taylor & Francis
Introduction: There is a growing body of evidence to suggest that chronic silent inflammation
is a key feature in abdominal obesity, metabolic syndrome, type 2 diabetes (T2DM) and …

[HTML][HTML] Targeting the inositol pyrophosphate biosynthetic enzymes in metabolic diseases

S Mukherjee, J Haubner, A Chakraborty - Molecules, 2020 - mdpi.com
In mammals, a family of three inositol hexakisphosphate kinases (IP6Ks) synthesizes the
inositol pyrophosphate 5-IP7 from IP6. Genetic deletion of Ip6k1 protects mice from high fat …

Naringin activates AMPK resulting in altered expression of SREBPs, PCSK9, and LDLR to reduce body weight in obese C57BL/6J mice

GG Sui, HB Xiao, XY Lu, ZL Sun - Journal of agricultural and food …, 2018 - ACS Publications
Previous investigations have shown molecular cross-talk among activated adenosine
monophosphate-activated protein kinase (AMPK), proprotein convertase subtilisin/kexin …

[HTML][HTML] Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9)

Y Wang, J Ye, J Li, C Chen, J Huang, P Liu… - Cardiovascular …, 2016 - Springer
Background Abnormalities in lipid and glucose metabolism are constantly observed in type
2 diabetes. However, these abnormalities can be ameliorated by polydatin. Considering the …

Conditioned media from adipose tissue derived mesenchymal stem cells reverse insulin resistance in cellular models

N Shree, RR Bhonde - Journal of Cellular Biochemistry, 2017 - Wiley Online Library
The link between insulin resistance (IR) and type 2 diabetes has been recognized for a long
time. Type 2 diabetes is often associated with basal hyperinsulinemia, reduced sensitivity to …

Human adipose tissue mesenchymal stem cells as a novel treatment modality for correcting obesity induced metabolic dysregulation

N Shree, S Venkategowda… - International Journal of …, 2019 - nature.com
Objective Obesity induced metabolic dysregulation results in cluster of chronic conditions
mainly hyperglycemia, hyperinsulinemia, dyslipidemia, diabetes, cardiovascular …

Targeting AMPK: from ancient drugs to new small-molecule activators

B Guigas, B Viollet - AMP-activated Protein Kinase, 2016 - Springer
The AMP-activated protein kinase (AMPK) is an evolutionary conserved and ubiquitously
expressed serine/threonine kinase mainly acting as a key regulator of cellular energy …

The anti diabetic and anti obesity effect of Memecylon umbellatum extract in high fat diet induced obese mice

V Sunil, N Shree, MV Venkataranganna… - Biomedicine & …, 2017 - Elsevier
In recent years, obesity and diabetes have become the epidemic mainly due to fast food and
lifestyle changes. Several herbs have been claimed to control diabetes and obesity …

[HTML][HTML] Novel direct AMPK activator suppresses non-small cell lung cancer through inhibition of lipid metabolism

X Chen, C Xie, XX Fan, ZB Jiang, VKW Wong, JH Xu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Drug resistance is becoming an obstacle in anti-cancer therapies. For target-based therapy
of lung cancer, gefitinib, as the first generation of tyrosine kinase inhibitors (TKIs) …

Treatment with adipose derived mesenchymal stem cells and their conditioned media reverse carrageenan induced paw oedema in db/db mice

N Shree, S Venkategowda, MV Venkatranganna… - Biomedicine & …, 2017 - Elsevier
Mesenchymal stem cells are known for anti inflammatory and immunomodulatory activities.
The aim of our study was to evaluate the effect of human adipose derived mesenchymal …